Brief: FDA Issues Emergency Use Authorization For Simparica Trio To Treat New World Screwworm In Dogs, Puppies
13/08/2026 18:31
BRIEF-FDA Issues Emergency Use Authorization For Simparica Trio To Treat New World Screwworm In Dogs, Puppies Aug 13 (Reuters) - US FDA:
US FDA - ISSUES EMERGENCY USE AUTHORIZATION FOR SIMPARICA TRIO TO TREAT NEW WORLD SCREWWORM IN DOGS & PUPPIES
US FDA - SIMPARICA TRIO EMERGENCY USE AUTHORIZATION SPONSORED BY ZOETIS BASED IN KALAMAZOO, MICHIGAN
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zoetis
See all newsBrief: Zoetis Receives FDA Approval For Convenia® Rtu For Dogs (Cefovecin Injectable Suspension), Helping More Medium And Large Dogs Access Single-Injection Treatment
Brief: FDA Approves Ready-To-Use Cefovecin Injectable For Treatment Of Certain Skin Infections In Dogs
U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan Materials
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs
Brief: FDA Issues Emergency Use Authorization For Simparica Trio To Treat New World Screwworm In Dogs, Puppies